Table II.
Clinical characteristics of patients (n=11).
| Characteristic | Group A | Group B | P-value |
|---|---|---|---|
| Male:female | 3:3 | 2:3 | 1.000a |
| Age, median (IQR) | 43 (36–48) | 58 (39–60) | 0.429b |
| Disease duration, years, median (IQR) | 11.6 (4.7–12.1) | 10.0 (2.5–20.5) | 0.792b |
| Behavior (first attack/relapse-remitting/chronic-persistent) | 1/3/2 | 0/3/2 | 0.632a |
| Location (pancolitis/left-sided/proctitis) | 3/1/2 | 3/2/0 | 0.323a |
| Rachmilewitz CAI, median (IQR) | 4 (3.0–4.8) | 3 (2.0–4.0) | 0.256b |
| Mayo score at baseline, median (IQR) | 6 (4.3–6.0) | 5 (4.0–5.0) | 0.562b |
| UCEIS, median (IQR) | 4 (3.0–4.8) | 3 (3.0–4.0) | 0.762b |
| Medication | |||
| 5-ASA (time-dependent/pH-dependent) | 6/0 | 3/2 | 0.353a |
| Azathioprine (yes/no) | 2/4 | 2/3 | 1.000a |
| Probiotics (yes/no) | 2/4 | 2/3 | 1.000a |
a
χ2 test.
b
Mann-Whitney's U test. IQR, interquartile range; CAI, clinical activity index; UCEIS, ulcerative colitis endoscopic index of severity; 5-ASA, 5-amynosalicylate.